Business
Artizen Succesfully Launched New Product Line
Artizen Succesfully Launched New Product Line.
About this update from Pervasip Corp.
[{"type":"text","content":"\n SEATTLE, WASHINGTON, July 28, 2022 (GLOBE NEWSWIRE) -- Pervasip Corp. (OTC: PVSP) (“Pervasip” or the “Company”), a developer of companies and technologies in high value emerging markets, together with Zen Asset Management today announced that its partnership with BGGTG successfully launched the first of several new brands. Utilizing Artizen biomass grown by independent cultivators, the new partnership has resulted in successfully producing high quality products manufactured by its independent laboratories and expanding sales of new Dabs4Less and Vape4Less brands. Based on that initial success the partners have agreed to consider additional product lines and expanding the initially contemplated alliance. With yields up in all gardens there is an opportunity to expand into new product categories and gain additional market share. Combined with the development of a new flower brand (stay tuned!) to launch in September, broadening the concentrates and vape offering, and expanding its stable of brands, efforts are made to increase sales and marketing capabilities and resources. Pervasip CorporationPervasip Corp., a developer of companies and technologies in high value emerging markets, owns Artizen Corporation and its subsidiary, Zen Asset Management LLC, a diversified asset management company founded to acquire, develop, and support companies and technologies in the cannabis industry. ZAM’s existing clients operate four licensed cannabis cultivation and one processing facility in Washington. Most of the biomass produced by these independent cultivators has been sold historically under the Artizen™ brand, including all-time top selling products in flower in Washington state. Additional information on Artizen-branded products is available online at www.artizencannabis.com. Pervasip additionally owns 5% of KRTL Biotech, Inc., a developer of biotechnologies with a focus on pharmaceutical applications of cannabinol and psilocybin. Additional information on KRTL is available online at www.krtlbiotech.com. Additional information on Pervasip can be found at www.pervasip.net. Forward-Looking StatementsThis news release contains statements and information that, to the extent that they are not historical fact, may constitute “forward-looking information” within the meaning of applicable securit...